JCIA
WST icon

Jackson Creek Investment Advisors’s West Pharmaceutical WST Stock Holding History

Jackson Creek Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,106
Closed -$865K – 387
2022
Q1 		$865K Sell
2,106
-111
-5% -$43.5K 0.32% 172
2021
Q4 		$1.04M Sell
2,217
-133
-6% -$57.2K 0.37% 140
2021
Q3 		$998K Sell
2,350
-94
-4% -$39.6K 0.37% 147
2021
Q2 		$878K Buy
+2,444
New +$808K 0.33% 170

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Jackson Creek Investment Advisors's WST Position: Q2 2022 in Review

Jackson Creek Investment Advisors sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 2,106 shares — an estimated $865K sold.

Jackson Creek Investment Advisors first reported a position in WST in Q2 2021 and held it in 4 quarters. The position peaked at $1.04M in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Jackson Creek Investment Advisors reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 2,106 West Pharmaceutical shares in Q2 2022, an estimated $865K.
  • Jackson Creek Investment Advisors first reported a position in West Pharmaceutical in Q2 2021 and held it in 4 quarters.
  • Jackson Creek Investment Advisors's West Pharmaceutical position peaked at $1.04M in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.